The role of peptidoglycan in pathogenesis

Current Opinion in Microbiology

Volumn 8, Issue 1, 2005, Pages 46-53

  Boneca, Ivo G ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; CARBOXYL GROUP; CYTOTOXIN; LYSOZYME; PEPTIDASE; PEPTIDOGLYCAN; PROTEIN DERIVATIVE;

BACTERIAL VIRULENCE; BIOLISTIC TRANSFORMATION; BORDETELLA PERTUSSIS; CHEMICAL MODIFICATION; CORRELATION ANALYSIS; ESCHERICHIA COLI; FRAGMENTATION REACTION; GENE SEQUENCE; HELICOBACTER PYLORI; HOST PATHOGEN INTERACTION; HUMAN; LISTERIA MONOCYTOGENES; MOLECULAR MECHANICS; MUTATIONAL ANALYSIS; NEISSERIA GONORRHOEAE; NEISSERIA MENINGITIDIS; NONHUMAN; PATHOGENESIS; PROTEIN DEGRADATION; REVIEW; STREPTOCOCCUS PNEUMONIA; TRACHEA;

BACTERIA (MICROORGANISMS); BORDETELLA; BORDETELLA PERTUSSIS; ESCHERICHIA COLI; HELICOBACTER; HELICOBACTER PYLORI; LISTERIA; LISTERIA MONOCYTOGENES; NEISSERIA; NEISSERIA GONORRHOEAE; NEISSERIA MENINGITIDIS; STREPTOCOCCUS; STREPTOCOCCUS PNEUMONIAE;

EID: 13444266131     PISSN: 13695274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mib.2004.12.008     Document Type: Review

References (57)

1. J.V. Holtje Growth of the stress-bearing and shape-maintaining murein sacculus of Escherichia coli Microbiol Mol Biol Rev 62 1998 181 203
2. K.H. Schleifer, and O. Kandler Peptidoglycan types of bacterial cell walls and their taxonomic implications Bacteriol Rev 36 1972 407 477
3. R. Schwandner, R. Dziarski, H. Wesche, M. Rothe, and C.J. Kirschning Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2 J Biol Chem 274 1999 17406 17409
4. O. Takeuchi, K. Hoshino, T. Kawai, H. Sanjo, H. Takada, T. Ogawa, K. Takeda, and S. Akira Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components Immunity 11 1999 443 451
5. A. Yoshimura, E. Lien, R.R. Ingalls, E. Tuomanen, R. Dziarski, and D. Golenbock Cutting edge: Recognition of gram-positive bacterial cell wall components by the innate immune system occurs via toll-like receptor 2 J Immunol 163 1999 1 5
6. A. Yoshimura, H. Takada, T. Kaneko, I. Kato, D. Golenbock, and Y. Hara Structural requirements of muramylpeptides for induction of Toll-like receptor 2-mediated NF-kappa B activation in CHO cells J Endotoxin Res 6 2000 407 410
7. L.H. Travassos, S.E. Girardin, D.J. Philpott, D. Blanot, M.A. Nahori, C. Werts, and I.G. Boneca Toll-like receptor 2-dependent bacterial sensing does not occur via peptidoglycan recognition EMBO Rep 5 2004 1000 1006
8. ••]).
9. ••]).
10. S.E. Girardin, L.H. Travassos, M. Herve, D. Blanot, I.G. Boneca, D.J. Philpott, P.J. Sansonetti, and D. Mengin-Lecreulx Peptidoglycan molecular requirements allowing detection by Nod1 and Nod2 J Biol Chem 278 2003 41702 41708 This work describes a detailed study of the muropeptide structural requirements for Nod1 and Nod2 sensing, which provides a better understanding of the types of peptidoglycans detected by the Nods.
11. ••]).
12. ••]).
13. Y.H. Sun, S. Bakshi, R. Chalmers, and C.M. Tang Functional genomics of Neisseria meningitidis pathogenesis Nat Med 6 2000 1269 1273
14. J.T. Park Why does Escherichia coli recycle its cell wall peptides? Mol Microbiol 17 1995 421 426
15. E. Tuomanen, H. Liu, B. Hengstler, O. Zak, and A. Tomasz The induction of meningeal inflammation by components of the pneumococcal cell wall J Infect Dis 151 1985 859 868
16. A. Fox, R.R. Brown, S.K. Anderle, C. Chetty, W.J. Cromartie, H. Gooder, and J.H. Schwab Arthropathic properties related to the molecular-weight of peptidoglycan-polysaccharide polymers of steptococcal cell walls Infect Immun 35 1982 1003 1010
17. •]).
18. ••]), reinforcing the notion that PG dynamics has a central role in its pathogenesis and the resulting host innate response.
19. E.D. Segal, C. Lange, A. Covacci, L.S. Tompkins, and S. Falkow Induction of host signal transduction pathways by Helicobacter pylori Proc Natl Acad Sci USA 94 1997 7595 7599
20. W. Fischer, J. Püls, R. Buhrdorf, B. Gebert, S. Odenbreit, and R. Haas Systematic mutagenesis of the Helicobacter pylori cag pathogenicity island: essential genes for CagA translocation in host cells and induction of interleukin-8 Mol Microbiol 42 2001 1337 1348
21. J. Viala, C. Chaput, I.G. Boneca, A. Cardona, S.E. Girardin, A.P. Moran, R. Athman, S. Mémet, M. Huerre, and A.J. Coyle Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island Nat Immunol 5 2004 1166 1174 This work presents elegant data demonstrating that extracellular pathogens can induce a host response via nucleotide-binding oligomerization domain (Nod)1. The work shows the essential role of a type-IV secretion system in translocating small peptidoglycan (PG) fragments into the cytosol of epithelial cells. Further, the response is dependent on a functional lytic transglycosylase, Slt.
22. J.E. Graham, R.M. Peek, U. Krishna, and T.L. Cover Global analysis of Helicobacter pylori gene expression in human gastric mucosa Gastroenterology 123 2002 1637 1648
23. S.E. Girardin, R. Tournebize, M. Mavris, A.L. Page, X. Li, G.R. Stark, J. Bertin, P.S. DiStefano, M. Yaniv, and P.J. Sansonetti CARD4/Nod1 mediates NF-kappa B and JNK activation by invasive Shigella flexneri EMBO Rep 2 2001 736 742
24. C. Bartoleschi, M.C. Pardini, C. Scaringi, M.C. Martino, C. Pazzani, and M.L. Bernardini Selection of Shigella flexneri candidate virulence genes specifically induced in bacteria resident in host cell cytoplasm Cell Microbiol 4 2002 613 626
25. M.A. Melly, Z.A. McGee, and R.S. Rosenthal Ability of monomeric peptidoglycan fragments from Neisseria gonorrhoeae to damage human fallopian-tube mucosa J Infect Dis 149 1984 378 386
26. R.S. Rosenthal, W. Nogami, B.T. Cookson, W.E. Goldman, and W.J. Folkening Major fragment of soluble peptidoglycan released from growing Bordetella pertussis is tracheal cytotoxin Infect Immun 55 1987 2117 2120
27. D.R. Cundell, K. Kanthakumar, G.W. Taylor, W.E. Goldman, T. Flak, P.J. Cole, and R. Wilson Effect of tracheal cytotoxin from Bordetella pertussis on human neutrophil function in vitro Infect Immun 62 1994 639 643
28. A.J. Clarke, and C. Dupont O-acetylated peptidoglycan: its occurrence, pathobiological significance, and biosynthesis Can J Microbiol 38 1992 85 91
29. N. Ohno, T. Yadomae, and T. Miyazaki Identification of 2-amino-2-deoxyglucose residues in the peptidoglycan of Streptococcus pneumoniae Carbohydr Res 107 1982 152 155
30. W. Vollmer, and A. Tomasz The pgdA gene encodes for a peptidoglycan N-acetylglucosamine deacetylase in Streptococcus pneumoniae J Biol Chem 275 2000 20496 20501
31. W. Vollmer, and A. Tomasz Peptidoglycan N-acetylglucosamine deacetylase, a putative virulence factor in Streptococcus pneumoniae Infect Immun 70 2002 7176 7178
32. A. Folkesson, S. Eriksson, M. Andersson, J.T. Park, and S. Normark Components of the peptidoglycan-recycling pathway modulate invasion and intracellular survival of Salmonella enterica serovar Typhimurium Cell Microbiol 2004 10.1111/j.1462-5822.2004.00443.x
33. F. Ellouz, A. Adam, R. Ciorbaru, and E. Lederer Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives Biochem Biophys Res Commun 59 1974 1317 1325
34. S. Kotani, Y. Watanabe, T. Shimono, K. Harada, and T. Shiba Correlation between the immunoadjuvant activities and pyrogenicities of synthetic N-acetylmuramyl-peptides or -amino acids Biken J 19 1976 9 13
35. C. Leclerc, D. Juy, and L. Chedid Inhibitory and stimulatory effects of a synthetic glycopeptide (MDP) on the in vitro PFC response: factors affecting the response Cell Immunol 42 1979 336 343
36. N.P. Cummings, M.J. Pabst, and RB. Johnston Jr. Activation of macrophages for enhanced release of superoxide anion and greater killing of Candida albicans by injection of muramyl dipeptide J Exp Med 152 1980 1659 1669
37. M.J. Pabst, N.P. Cummings, T. Shiba, S. Kusumoto, and S. Kotani Lipophilic derivative of muramyl dipeptide is more active than muramyl dipeptide in priming macrophages to release superoxide anion Infect Immun 29 1980 617 622
38. W.H. Dokter, A.J. Dijkstra, S.B. Koopmans, B.K. Stulp, W. Keck, M.R. Halie, and E. Vellenga G(Anh)MTetra, a natural bacterial cell wall breakdown product, induces interleukin-1 beta and interleukin-6 expression in human monocytes. A study of the molecular mechanisms involved in inflammatory cytokine expression J Biol Chem 269 1994 4201 4206
39. M.R. Gold, C.L. Miller, and R.I. Mishell Soluble non-cross-linked peptidoglycan polymers stimulate monocyte-macrophage inflammatory functions Infect Immun 49 1985 731 741
40. K.M. Kengatharan, S. De Kimpe, C. Robson, S.J. Foster, and C. Thiemermann Mechanism of gram-positive shock: identification of peptidoglycan and lipoteichoic acid moieties essential in the induction of nitric oxide synthase, shock, and multiple organ failure J Exp Med 188 1998 305 315
41. J. Greenblatt, R.J. Boackle, and J.H. Schwab Activation of the alternate complement pathway by peptidoglycan from streptococcal cell wall Infect Immun 19 1978 296 303
42. I. Lowy, C. Leclerc, and L. Chedid Induction of antibodies directed against self and altered-self determinants by a synthetic adjuvant, muramyl dipeptide and some of its derivatives Immunology 39 1980 441 450
43. T.J. Fleming, D.E. Wallsmith, and R.S. Rosenthal Arthropathic properties of gonococcal peptidoglycan fragments: implications for the pathogenesis of disseminated gonococcal disease Infect Immun 52 1986 600 608
44. J.M. Krueger, J.R. Pappenheimer, and M.L. Karnovsky Sleep-promoting effects of muramyl peptides Proc Natl Acad Sci USA 79 1982 6102 6106
45. J.M. Krueger, J.R. Pappenheimer, and M.L. Karnovsky The composition of sleep-promoting factor isolated from human urine J Biol Chem 257 1982 1664 1669
46. P.E. Dunn, W. Dai, M.R. Kanost, and C.X. Geng Soluble peptidoglycan fragments stimulate antibacterial protein synthesis by fat body from larvae of Manduca sexta Dev Comp Immunol 9 1985 559 568
47. W. Langhans, R. Harlacher, G. Balkowski, and E. Scharrer Comparison of the effects of bacterial lipopolysaccharide and muramyl dipeptide on food intake Physiol Behav 47 1990 805 813
48. N. Autret, I. Dubail, P. Trieu-Cuot, P. Berche, and A. Charbit Identification of new genes involved in the virulence of Listeria monocytogenes by signature-tagged transposon mutagenesis Infect Immun 69 2001 2054 2065
49. G.W. Lau, S. Haataja, M. Lonetto, S.E. Kensit, A. Marra, A.P. Bryant, D. McDevitt, D.A. Morrison, and D.W. Holden A functional genomic analysis of type 3 Streptococcus pneumoniae virulence Mol Microbiol 40 2001 555 571
50. A. Polissi, A. Pontiggia, G. Feger, M. Altieri, H. Mottl, L. Ferrari, and D. Simon Large-scale identification of virulence genes from Streptococcus pneumoniae Infect Immun 66 1998 5620 5629
51. D.L. Hava, and A. Camilli Large-scale identification of serotype 4 Streptococcus pneumoniae virulence factors Mol Microbiol 45 2002 1389 1406
52. A.L. Jones, K.M. Knoll, and C.E. Rubens Identification of Streptococcus agalactiae virulence genes in the neonatal rat sepsis model using signature-tagged mutagenesis Mol Microbiol 37 2000 1444 1455
53. M. Harper, J.D. Boyce, I.W. Wilkie, and B. Adler Signature-tagged mutagenesis of Pasteurella multocida identifies mutants displaying differential virulence characteristics in mice and chickens Infect Immun 71 2003 5440 5446
54. P. Lestrate, R.M. Delrue, I. Danese, C. Didembourg, B. Taminiau, P. Mertens, X. De Bolle, A. Tibor, C.M. Tang, and J.J. Letesson Identification and characterization of in vivo attenuated mutants of Brucella melitensis Mol Microbiol 38 2000 543 551
55. M.A. Herbert, S. Hayes, M.E. Deadman, C.M. Tang, D.W. Hood, and E.R. Moxon Signature tagged mutagenesis of Haemophilus influenzae identifies genes required for in vivo survival Microb Pathog 33 2002 211 223
56. T.A. Hunt, C. Kooi, P.A. Sokol, and M.A. Valvano Identification of Burkholderia cenocepacia genes required for bacterial survival in vivo Infect Immun 72 2004 4010 4022
57. L.S. Burall, J.M. Harro, X. Li, C.V. Lockatell, S.D. Himpsl, J.R. Hebel, D.E. Johnson, and H.L. Mobley Proteus mirabilis genes that contribute to pathogenesis of urinary tract infection: identification of 25 signature-tagged mutants attenuated at least 100-fold Infect Immun 72 2004 2922 2938